Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) EBIT (2016 - 2025)

Historic EBIT for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $208000.0.

  • AtriCure's EBIT rose 10280.89% to $208000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.5 million, marking a year-over-year increase of 2253.35%. This contributed to the annual value of -$40.0 million for FY2024, which is 4995.69% down from last year.
  • Latest data reveals that AtriCure reported EBIT of $208000.0 as of Q3 2025, which was up 10280.89% from -$6.2 million recorded in Q2 2025.
  • AtriCure's 5-year EBIT high stood at $98.7 million for Q3 2021, and its period low was -$15.9 million during Q1 2021.
  • Moreover, its 5-year median value for EBIT was -$8.1 million (2023), whereas its average is -$3.5 million.
  • In the last 5 years, AtriCure's EBIT skyrocketed by 257228.76% in 2021 and then tumbled by 11086.76% in 2022.
  • Over the past 5 years, AtriCure's EBIT (Quarter) stood at -$12.5 million in 2021, then skyrocketed by 66.92% to -$4.1 million in 2022, then plummeted by 109.57% to -$8.7 million in 2023, then tumbled by 67.55% to -$14.5 million in 2024, then soared by 101.43% to $208000.0 in 2025.
  • Its EBIT stands at $208000.0 for Q3 2025, versus -$6.2 million for Q2 2025 and -$6.0 million for Q1 2025.